In its second safety alert this year, Smiths Medical has issued a letter to its customers detailing a pair of potential issues with the infusion sets used alongside its CADD line of infusion systems.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A novel extended-wear insulin infusion ...
Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
A joint study between Amsterdam University Medical Centers and MEDLAB analyzed over two dozen glucose sensors, insulin pumps, and insulin infusion sets to identify the chemicals present in these ...
Medtronic plc (NYSE: MDT) has launched the Medtronic Extended infusion set in the U.S., the first and only infusion set labeled for up to 7-day wear. An infusion set is tubing that delivers insulin ...
DUBLIN, June 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced data on its extended wear infusion set presented at the virtual 80th Scientific ...
As per Future Market Insights (FMI), the global Multi-Therapy Infusion Pumps Market is set to be valued at US$ 370.44 million in 2023. From 2023 to 2033, global multi-therapy infusion pump sales are ...
Medtronic MiniMed Paradigm Insulin Infusion Sets have been recalled, according to an FDA Med Watch report. The recall is due to a malfunction affecting products manufactured from October 2001 through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback